Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas

Arch Dermatol. 2004 Oct;140(10):1284-5. doi: 10.1001/archderm.140.10.1284-b.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aminoquinolines / administration & dosage
  • Aminoquinolines / therapeutic use*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Basal Cell / pathology
  • Extremities
  • Female
  • Humans
  • Imiquimod
  • Male
  • Neck
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Thorax
  • Treatment Outcome

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod